Outstanding questions and ongoing studies on the use of NOACs

Oct. 7, 2016 - Berg en Dal, The Netherlands - Prof. Chris Granger, MD (Durham, NC, USA)

Triple therapy in patients with atrial fibrillation and who experienced ACS or who have a coronary stent 0:19
Do patients with subclinical AF benefit from anticoagulant therapy? 1:16
Treatment of embolic stroke with unknown origin 1:41
Anticoagulation of patients with AF and renal failure on haemodialysis 2:20
Optimising anticoagulant treatment in patients needing stroke prevention 2:44